Cerevel Therapeutics Holdings, Inc.·4

Feb 5, 6:45 PM ET

DiPietro Kenneth 4

4 · Cerevel Therapeutics Holdings, Inc. · Filed Feb 5, 2021

Insider Transaction Report

Form 4
Period: 2021-02-03
DiPietro Kenneth
Chief Human Resources Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-03+175,438175,438 total
    Exercise: $12.70Exp: 2031-02-03Common Stock (175,438 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION